Murphy Polly A.
- SEC CIK
- 0001829248
In the past year, 1 open-market purchase filing worth $25.4K and no sales.
Current role at each company
- AVIR Atea Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- CELC Celcuity Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Murphy Polly A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVIR Atea Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 18 | 3 days | Murphy Polly A.Director | PPurchase | +6.10K | $4.17 | +$25.4K | +7.1%92.1K after | Amended |
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Murphy Polly A.Director | PPurchase | +12.0K | $8.57 | +$102.8K | +106.2%23.3K after |
CELC Celcuity Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Murphy Polly A.Director | PPurchase | +5.00K | $9.68 | +$48.4K | New position5.00K after |